CVSI stock is down over 20% since CV Sciences Inc (OTCQB:CVSI) reported its third-quarter earnings, which fell short of analysts’ expectations due to increased competition in the CBD market.
CVSI Stock Squeezed by CompetitionThe San Diego-based CBD manufacturer posted revenue of $12.6 million USD for the three months ended September 30, a drop of 7% from the same period last year. Profit for the quarter was $8.4 million, down 15% from the previous year. CVSI came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.01, compared to earnings ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.